Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,980 | 208 | 91.8% |
| Education | $355.83 | 7 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,248 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $337.30 | 18 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $275.35 | 18 | $0 (2024) |
| Antares Pharma, Inc. | $241.70 | 12 | $0 (2024) |
| ABBVIE INC. | $210.99 | 14 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $177.68 | 3 | $0 (2024) |
| 180 Medical, Inc. | $165.72 | 10 | $0 (2019) |
| Teleflex LLC | $164.82 | 2 | $0 (2023) |
| NeoTract Inc. | $153.80 | 4 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $106.93 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $752.28 | 25 | Astellas Pharma US Inc ($198.37) |
| 2023 | $471.19 | 19 | ConvaTec Inc. ($94.64) |
| 2022 | $170.32 | 10 | UROVANT SCIENCES INC ($38.71) |
| 2021 | $403.81 | 21 | Astellas Pharma US Inc ($214.53) |
| 2020 | $276.94 | 18 | Antares Pharma, Inc. ($64.36) |
| 2019 | $768.41 | 42 | Astellas Pharma US Inc ($295.99) |
| 2018 | $740.26 | 44 | Astellas Pharma US Inc ($196.51) |
| 2017 | $752.38 | 36 | Astellas Pharma US Inc ($240.96) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Oncology | ||||||
| 10/07/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $76.81 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $75.36 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 08/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Urology | ||||||
| 08/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/15/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Oncology | ||||||
| 04/15/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: UROLOGY | ||||||
| 03/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: HORMONE THERAPY | ||||||
| 03/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Oncology | ||||||
| 03/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 02/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $59.07 | General |
| Category: Oncology | ||||||
| 02/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Oncology | ||||||
| 02/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: UROLOGY | ||||||
| 01/19/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 708 | 884 | $124,631 | $43,898 |
| 2022 | 9 | 576 | 731 | $59,787 | $28,716 |
| 2021 | 10 | 587 | 877 | $140,573 | $40,670 |
| 2020 | 9 | 570 | 752 | $60,460 | $21,988 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 278 | $36,825 | $15,798 | 42.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 124 | 124 | $25,886 | $8,713 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 99 | $20,493 | $8,351 | 40.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 32 | 37 | $17,612 | $6,262 | 35.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 33 | 34 | $10,234 | $1,984 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 43 | $3,655 | $1,654 | 45.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 54 | 71 | $2,982 | $524.40 | 17.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 91 | 113 | $5,311 | $244.74 | 4.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 17 | $357.00 | $142.80 | 40.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 41 | $574.00 | $139.81 | 24.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 26 | 27 | $702.00 | $83.97 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 252 | $26,551 | $13,945 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 78 | $13,442 | $6,789 | 50.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $7,142 | $2,729 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,995 | $1,787 | 44.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 20 | 21 | $2,520 | $1,217 | 48.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 28 | $2,601 | $1,038 | 39.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 158 | 222 | $2,220 | $880.38 | 39.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 34 | 37 | $854.00 | $216.72 | 25.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 33 | 33 | $462.00 | $112.53 | 24.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 11 | 108 | $87,805 | $14,563 | 16.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 226 | $22,924 | $13,203 | 57.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 69 | 69 | $10,626 | $4,841 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 36 | $5,580 | $2,844 | 51.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 23 | 31 | $4,066 | $1,554 | 38.2% |
About Dr. William Crowe, MD
Dr. William Crowe, MD is a Urology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750387239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Crowe, MD has received a total of $4,336 in payments from pharmaceutical and medical device companies, with $752.28 received in 2024. These payments were reported across 215 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,980).
As a Medicare-enrolled provider, Crowe has provided services to 2,441 Medicare beneficiaries, totaling 3,244 services with total Medicare billing of $135,272. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lexington, KY
- Active Since 06/21/2005
- Last Updated 07/07/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1750387239
Products in Payments
- MYRBETRIQ (Drug) $424.22
- XIAFLEX (Biological) $288.48
- XTANDI (Drug) $265.55
- Erleada (Drug) $207.61
- Xtandi (Drug) $180.23
- AQUABEAM SYSTEM (Device) $177.68
- UroLift (Device) $153.80
- XYOSTED (Drug) $140.27
- UroLift System (Device) $118.50
- ERLEADA (Drug) $109.82
- Myrbetriq (Drug) $109.09
- ORGOVYX (Drug) $106.93
- Rezum (Device) $85.53
- Nubeqa (Drug) $81.57
- SELF-CATH (Device) $67.98
- VESICARE (Drug) $66.87
- NOCDURNA (Drug) $65.28
- OTREXUP (Drug) $64.36
- ELIGARD (Drug) $63.71
- Axumin (Drug) $63.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lexington
Thomas Slabaugh, Md, MD
Urology — Payments: $41,612
Stephen Monnig, M.d, M.D
Urology — Payments: $17,229
Alexandre Caillat, Md, MD
Urology — Payments: $11,339
Dr. John Bell, M.d, M.D
Urology — Payments: $11,176
Frances Martin, M.d, M.D
Urology — Payments: $11,085
Andrew Harris, Md, MD
Urology — Payments: $10,640